1. Home
  2. KLRS vs IOBT Comparison

KLRS vs IOBT Comparison

Compare KLRS & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLRS
  • IOBT
  • Stock Information
  • Founded
  • KLRS 2019
  • IOBT 2014
  • Country
  • KLRS United States
  • IOBT Denmark
  • Employees
  • KLRS N/A
  • IOBT 80
  • Industry
  • KLRS Biotechnology: Biological Products (No Diagnostic Substances)
  • IOBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLRS Health Care
  • IOBT Health Care
  • Exchange
  • KLRS Nasdaq
  • IOBT Nasdaq
  • Market Cap
  • KLRS 57.5M
  • IOBT 56.5M
  • IPO Year
  • KLRS N/A
  • IOBT 2021
  • Fundamental
  • Price
  • KLRS $6.99
  • IOBT $0.86
  • Analyst Decision
  • KLRS Buy
  • IOBT Strong Buy
  • Analyst Count
  • KLRS 1
  • IOBT 3
  • Target Price
  • KLRS N/A
  • IOBT $9.33
  • AVG Volume (30 Days)
  • KLRS 52.0K
  • IOBT 266.2K
  • Earning Date
  • KLRS 05-15-2025
  • IOBT 05-13-2025
  • Dividend Yield
  • KLRS N/A
  • IOBT N/A
  • EPS Growth
  • KLRS N/A
  • IOBT N/A
  • EPS
  • KLRS N/A
  • IOBT N/A
  • Revenue
  • KLRS N/A
  • IOBT N/A
  • Revenue This Year
  • KLRS N/A
  • IOBT N/A
  • Revenue Next Year
  • KLRS N/A
  • IOBT N/A
  • P/E Ratio
  • KLRS N/A
  • IOBT N/A
  • Revenue Growth
  • KLRS N/A
  • IOBT N/A
  • 52 Week Low
  • KLRS $5.87
  • IOBT $0.66
  • 52 Week High
  • KLRS $24.15
  • IOBT $1.79
  • Technical
  • Relative Strength Index (RSI)
  • KLRS N/A
  • IOBT 41.66
  • Support Level
  • KLRS N/A
  • IOBT $0.85
  • Resistance Level
  • KLRS N/A
  • IOBT $0.94
  • Average True Range (ATR)
  • KLRS 0.00
  • IOBT 0.10
  • MACD
  • KLRS 0.00
  • IOBT -0.02
  • Stochastic Oscillator
  • KLRS 0.00
  • IOBT 8.13

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: